MD Pharma develops treatments of muscular disorders, focusing on muscular dystrophy

After a positive evaluation MD Pharma has recently been established and the development work is now initiated. The company develops treatments of muscular disorders, focusing on muscular dystrophy.

MD Pharma is based on research by Professor Madeleine Durbeej-Hjalt and Dr Virginie Carmignac at Lund University.

LU Bio position: 69,4%

Partners: LU Bio and inventors

More information will follow.